Published in Curr Opin Genet Dev on December 29, 2013
Substantial contribution of extrinsic risk factors to cancer development. Nature (2015) 2.46
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet (2015) 2.17
Clock-like mutational processes in human somatic cells. Nat Genet (2015) 1.91
Lagging-strand replication shapes the mutational landscape of the genome. Nature (2015) 1.63
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun (2015) 1.49
Whole-genome landscapes of major melanoma subtypes. Nature (2017) 1.40
Pathway-driven discovery of epilepsy genes. Nat Neurosci (2015) 1.00
A mutational signature in gastric cancer suggests therapeutic strategies. Nat Commun (2015) 0.96
Cancer prevention as part of precision medicine: 'plenty to be done'. Carcinogenesis (2015) 0.86
Stakeholders' perspectives on biobank-based genomic research: systematic review of the literature. Eur J Hum Genet (2015) 0.84
Mutation signatures implicate aristolochic acid in bladder cancer development. Genome Med (2015) 0.84
Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol (2015) 0.82
Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma. MBio (2017) 0.81
Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene (2015) 0.81
Analysis of cancer genomes reveals basic features of human aging and its role in cancer development. Nat Commun (2016) 0.81
How the environment shapes cancer genomes. Curr Opin Oncol (2015) 0.80
The role of the RAS pathway in iAMP21-ALL. Leukemia (2016) 0.79
Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis. PLoS Med (2016) 0.78
Clusters of Multiple Mutations: Incidence and Molecular Mechanisms. Annu Rev Genet (2015) 0.78
MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes. BMC Bioinformatics (2016) 0.78
Human Germline Mutation and the Erratic Evolutionary Clock. PLoS Biol (2016) 0.78
The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight (2016) 0.78
Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse. Cancer Sci (2016) 0.78
Frailty in childhood cancer survivors. Cancer (2014) 0.78
A shifting mutational landscape in 6 nutritional states: Stress-induced mutagenesis as a series of distinct stress input-mutation output relationships. PLoS Biol (2017) 0.78
Stress-induced mutation rates show a sigmoidal and saturable increase due to the RpoS sigma factor in Escherichia coli. Genetics (2014) 0.77
Ribonucleotides and Transcription-Associated Mutagenesis in Yeast. J Mol Biol (2016) 0.77
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients. PLoS One (2016) 0.76
The importance of extrinsic factors in the development of cancers. Mol Cell Oncol (2016) 0.75
Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours. Nat Commun (2016) 0.75
Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. Oncotarget (2016) 0.75
Disease evolution and heterogeneity in bilateral breast cancer. Am J Cancer Res (2016) 0.75
Revertant mosaicism repairs skin lesions in a patient with keratitis-ichthyosis-deafness syndrome by second-site mutations in connexin 26. Hum Mol Genet (2017) 0.75
Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia. J Investig Med (2016) 0.75
Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers. Sci Rep (2016) 0.75
Putative RNA-Directed Adaptive Mutations in Cancer Evolution. Transcription (2016) 0.75
Whole-genome sequencing identifies new genetic alterations in meningiomas. Oncotarget (2017) 0.75
Base changes in tumour DNA have the power to reveal the causes and evolution of cancer. Oncogene (2016) 0.75
The evolution of tumour phylogenetics: principles and practice. Nat Rev Genet (2017) 0.75
Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine. Genome Med (2016) 0.75
Transcription-associated events affecting genomic integrity. Philos Trans R Soc Lond B Biol Sci (2017) 0.75
*K-means and cluster models for cancer signatures. Biomol Detect Quantif (2017) 0.75
Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer. Biochim Biophys Acta (2017) 0.75
An alternative model for (breast) cancer predisposition. NPJ Breast Cancer (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature (1953) 47.27
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
p53 mutations in human cancers. Science (1991) 31.96
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
The cancer genome. Nature (2009) 23.13
Learning the parts of objects by non-negative matrix factorization. Nature (1999) 21.77
Signatures of mutational processes in human cancer. Nature (2013) 21.63
International network of cancer genome projects. Nature (2010) 20.35
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 14.33
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
A landscape of driver mutations in melanoma. Cell (2012) 12.61
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
The mutational landscape of lethal castration-resistant prostate cancer. Nature (2012) 11.82
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res (1994) 11.29
The landscape of cancer genes and mutational processes in breast cancer. Nature (2012) 11.24
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science (2010) 10.78
The life history of 21 breast cancers. Cell (2012) 10.59
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet (2012) 9.93
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71
Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40
Melanoma genome sequencing reveals frequent PREX2 mutations. Nature (2012) 7.77
Punctuated evolution of prostate cancer genomes. Cell (2013) 7.23
A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet (2005) 6.70
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet (2011) 6.43
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A (1991) 6.42
Exploring the genomes of cancer cells: progress and promise. Science (2011) 6.16
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell (2012) 6.07
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet (2011) 5.68
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23
RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell (2002) 5.14
Pyrimidine dimers in ultraviolet-irradiated DNA's. J Mol Biol (1966) 5.13
Recurrent R-spondin fusions in colon cancer. Nature (2012) 5.10
BAP1 loss defines a new class of renal cell carcinoma. Nat Genet (2012) 4.97
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet (2012) 4.84
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet (2012) 4.82
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
The genetic landscape of high-risk neuroblastoma. Nat Genet (2013) 4.71
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet (2013) 4.69
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet (2013) 3.94
The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res (2012) 3.80
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet (2011) 3.66
Deciphering signatures of mutational processes operative in human cancer. Cell Rep (2013) 3.61
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A (2011) 3.51
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat Genet (2012) 3.38
The genetic landscape of mutations in Burkitt lymphoma. Nat Genet (2012) 3.03
DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife (2013) 2.67
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet (2012) 2.64
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat Genet (2011) 2.36
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med (2013) 2.30
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
Ultraviolet-induced mutation and DNA repair. Annu Rev Microbiol (1969) 1.88
p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet (1991) 1.81
New approaches to understanding p53 gene tumor mutation spectra. Mutat Res (1999) 1.75
Mutation patterns in cancer genomes. Proc Natl Acad Sci U S A (2009) 1.69
Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res (1992) 1.46
Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect (1991) 1.44
Hypermutation at A-T base pairs: the A nucleotide replacement spectrum is affected by adjacent nucleotides and there is no reverse complementarity of sequences flanking mutated A and T nucleotides. J Immunol (2005) 1.43
Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol (2005) 1.35
Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol (2012) 1.33
Database and software for the analysis of mutations in the human p53 gene. Cancer Res (1994) 1.21
Carcinogens leave fingerprints. Nature (1992) 1.19
IDENTIFICATION OF THE ALTERED BASES IN MUTATED SINGLE-STRANDED DNA. II. IN VIVO MUTAGENESIS BY 5-BROMODEOXYURIDINE AND 2-AMINOPURINE. J Mol Biol (1964) 0.97
Transcription-coupled repair: impact on UV-induced mutagenesis in cultured rodent cells and mouse skin tumors. Mutat Res (2005) 0.96
On the mechanism of cancer induction by ultraviolet radiation. J Natl Cancer Inst (1950) 0.87
TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Mutagenesis (2001) 0.85